// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Norway, Netherlands, Sweden, Belgium, Denmark, Island topped the list as "free" in terms of media freedom.
The woman tried to escape herself, but enchanted by her beauty, the Turk caught her and dragged her to the barn, the story says.
The Aurora Prize will honor an Aurora Laureate each year until 2023, in remembrance of the eight years of the Armenian Genocide (1915 -1923).
According to Tigran Yegoryan, the court has returned the appeal, while the initiative has appealed the decision to the Court's president.
Partner news